Tuesday, May 7 2024 | Time 14:42 Hrs(IST)
image
Business EconomyPosted at: Oct 14 2022 4:26PM


C-CAMP signs pact with Agilent Technologies

Bengaluru, Oct 14 (UNI) The Centre for Cellular and Molecular Platform (C-CAMP) has signed an agreement with Agilent Technologies to pave the way for research and technology development in the sector of biosimilars and biopharmaceuticals, a core strength of both the organizations.
The agreement will primarily focus on mass spectrometry-based biotherapeutics/biosimilar characterization, a platform C-CAMP champions with its existing state-of-the art mass spectrometry facilities across proteomics, metabolomics, lipidomics, glycomics and biologics research.
Through this partnership, both organizations will leverage each other’s capabilities to hold joint training sessions and seminars for researchers across biopharma/biosimilars start-ups and established companies.
C-CAMP and Agilent will collaborate on product development and services for the biopharmaceutical industry, using the high-end scientific infrastructures and skill sets that both Agilent and C-CAMP share.
Dr Taslimarif Saiyed, C-CAMP CEO and Director, said: "C-CAMP is steadily growing in the area of biopharmaceuticals and this partnership will greatly benefit the delivery of deep-science technologies to the biopharma sector. With this MoU, the start-ups associated with C-CAMP can easily access their high-end mass spectrometry solutions and technologies."
Dr Shirshendu Mukherjee, Mission Director, BIRAC, congratulated both parties and said: "Science should not be limited to only bench level research and at BIRAC we are proud to have worked closely with C-CAMP in scouting for cutting-edge scientific ideas, converting them to technologies and solving important challenges while also exploiting their commercial potential.
"This partnership is a win-win for both C-CAMP and Agilent as it will provide access to high-end technology platforms such as Agilent’s to researchers, innovators and startups during the crucial product development phase."
Dr Samir Vyas, Agilent India Country General Manager, said: "This is a unique collaboration in India where Agilent’s partnership has a greater vision to align with a flagship program named ‘Innovate in India (I3)’, enabling an ecosystem to promote entrepreneurship and manufacturing capabilities."
C-CAMP facilitates bioscience research and innovation by providing training and services in addition to funding, incubation and entrepreneurship development support.
The organization is registered under the United States Food and Drug Administration (US FDA) to perform analyses towards active pharmaceutical ingredients, drug products, and drug substances.
With Agilent’s support, C-CAMP will be catalysing more research and development of biopharmaceuticals in compliance with the global regulatory framework in India.
C-CAMP is one of India’s premier innovation and technology hubs as well as one of the largest and most vibrant life sciences incubators in the country.
Agilent Technologies is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation toward advancing the quality of life.
The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide.
UNI BDN MR
Please log in to get detailed story.
Tags: #C-CAMP signs pact with Agilent Technologies
More News
Rupee opens flat against USD

Rupee opens flat against USD

07 May 2024 | 11:08 AM

Mumbai, May 7 (UNI) The rupee on Tuesday was seen unchanged at 83.49 against USD in the opening session on selling of US Dollar by bankers and exporters, dealers at the Foreign Exchange said.

see more..
Sensex falls over 200 points

Sensex falls over 200 points

07 May 2024 | 11:07 AM

Mumbai, May 7 (UNI) The BSE Sensex on Tuesday slipped 285.75 points at 73609.79 in opening session as selling was seen in Telecommunications, Utilities and Auto stocks.

see more..

USD Euro, Pound up; Yen down

07 May 2024 | 10:15 AM

Mumbai, May 7 (UNI) Following were the indicative currency rates and travellers' cheques
buying and selling rates.

see more..

Coromandel increases shareholding in Ecozen

06 May 2024 | 11:02 PM

Hyderabad, May 6 (UNI) Coromandel International Limited, India’s leading agri-solutions company, announced on Monday it is increasing its investment in Ecozen, a pioneering climate-smart technology solutions provider.

see more..

American Brew Crafts acquires Denzong Brewery in Odisha to fuel Eastern India Expansion

06 May 2024 | 10:42 PM

Hyderabad, May 6 (UNI) American Brew Crafts Pvt. Ltd. (ABCL), a leading brewing company renowned for its exceptional brews, announced on Monday its recent acquisition of Denzong Brewery, located in Odisha.

see more..
image